Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amastha Awaleha is an Ayurvedic herbal supplement developed by Mpil Wellness (manufactured by Maheshwari Pharmaceuticals (I) Ltd.) for the management of various respiratory conditions. It is formulated as a synergistic blend of over 30 standardized herbs, including key ingredients such as Vasa (*Adhatoda vasica*), Kantakari (*Solanum xanthocarpum*), Yashtimadhu (*Glycyrrhiza glabra*), and Tulsi (*Ocimum sanctum*). The supplement acts as a bronchodilator and expectorant, helping to relieve bronchial spasms, irritation, and congestion. It is indicated for conditions such as asthma, bronchitis, COPD, chronic cough, and naso-bronchial allergies. As a traditional Ayurvedic "Awaleha" (herbal paste), it aims to boost respiratory immunity and is available in both regular and sugar-free versions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amastha Awaleha.